Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)
Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –
Incyte operating margin
Operating margin is operating income as a percentage of revenue.
Incyte's operating margin for the twelve months ending Sep 30, 2026 was 10.4%. For fiscal 2025 it was 29.5%, against 1.4% the year before. The highest annual figure on record is 29.5% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29.5% | +28.0 |
| FY2024 | Dec 31, 2024 | 1.4% | −15.3 |
| FY2023 | Dec 31, 2023 | 16.8% | −0.3 |
| FY2022 | Dec 31, 2022 | 17.1% | −2.5 |
| FY2021 | Dec 31, 2021 | 19.6% | +29.5 |
| FY2020 | Dec 31, 2020 | -9.9% | −28.5 |
| FY2019 | Dec 31, 2019 | 18.6% | +11.8 |
| FY2018 | Dec 31, 2018 | 6.9% | +22.7 |
| FY2017 | Dec 31, 2017 | -15.8% | −29.0 |
| FY2016 | Dec 31, 2016 | 13.1% | +6.4 |
| FY2015 | Dec 31, 2015 | 6.7% | +7.7 |
| FY2014 | Dec 31, 2014 | -0.9% | +3.6 |
| FY2013 | Dec 31, 2013 | -4.5% | −4.9 |
| FY2012 | Dec 31, 2012 | 0.4% | +152.0 |
| FY2011 | Dec 31, 2011 | -151.6% | −159.9 |
| FY2010 | Dec 31, 2010 | 8.3% | +1516.8 |
| FY2009 | Dec 31, 2009 | -1508.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -45.5% | −78.0 |
| Q2 FY2026 | Jun 30, 2026 | 41.7% | −1.9 |
| Q1 FY2026 | Mar 31, 2026 | 23.7% | +4.2 |
| Q4 FY2025 | Dec 31, 2025 | 22.3% | −3.3 |
| Q3 FY2025 | Sep 30, 2025 | 32.5% | +19.6 |
| Q2 FY2025 | Jun 30, 2025 | 43.6% | +89.4 |
| Q1 FY2025 | Mar 31, 2025 | 19.5% | +9.1 |
| Q4 FY2024 | Dec 31, 2024 | 25.6% | +7.1 |
| Q3 FY2024 | Sep 30, 2024 | 12.8% | −10.5 |
| Q2 FY2024 | Jun 30, 2024 | -45.8% | −66.1 |
| Q1 FY2024 | Mar 31, 2024 | 10.4% | +7.4 |
| Q4 FY2023 | Dec 31, 2023 | 18.5% | +10.9 |
| Q3 FY2023 | Sep 30, 2023 | 23.4% | +6.6 |
| Q2 FY2023 | Jun 30, 2023 | 20.3% | −7.6 |
| Q1 FY2023 | Mar 31, 2023 | 3.1% | −12.8 |
| Q4 FY2022 | Dec 31, 2022 | 7.6% | −5.3 |
| Q3 FY2022 | Sep 30, 2022 | 16.8% | −12.1 |
| Q2 FY2022 | Jun 30, 2022 | 27.9% | +8.0 |
| Q1 FY2022 | Mar 31, 2022 | 15.9% | −0.4 |
| Q4 FY2021 | Dec 31, 2021 | 12.8% | −8.0 |
| Q3 FY2021 | Sep 30, 2021 | 29.0% | +28.1 |
| Q2 FY2021 | Jun 30, 2021 | 20.0% | −13.6 |
| Q1 FY2021 | Mar 31, 2021 | 16.3% | +133.1 |
| Q4 FY2020 | Dec 31, 2020 | 20.8% | +4.4 |
| Q3 FY2020 | Sep 30, 2020 | 0.9% | −23.5 |
| Q2 FY2020 | Jun 30, 2020 | 33.5% | +14.9 |
| Q1 FY2020 | Mar 31, 2020 | -116.8% | −131.7 |
| Q4 FY2019 | Dec 31, 2019 | 16.4% | +0.9 |
| Q3 FY2019 | Sep 30, 2019 | 24.4% | +17.4 |
| Q2 FY2019 | Jun 30, 2019 | 18.6% | +2.6 |
| Q1 FY2019 | Mar 31, 2019 | 14.9% | +32.4 |
| Q4 FY2018 | Dec 31, 2018 | 15.5% | +45.3 |
| Q3 FY2018 | Sep 30, 2018 | 6.9% | +3.0 |
| Q2 FY2018 | Jun 30, 2018 | 16.0% | +13.7 |
| Q1 FY2018 | Mar 31, 2018 | -17.6% | +17.1 |
| Q4 FY2017 | Dec 31, 2017 | -29.8% | −42.7 |
| Q3 FY2017 | Sep 30, 2017 | 3.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 2.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -34.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 12.9% | – |
See a number that looks wrong?